MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12206994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-alpha inhibits proliferation in human T lymphocytes by abrogation of interleukin 2-induced changes in cell cycle-regulatory proteins.

  1999cited by this paper
• Nuclear translocation of mitogen‐activated protein kinase p42MAPK during the ongoing cell cycle

  1999cited by this paper
• Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin.

  1998cited by this paper
• Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

  1998cited by this paper
• Effect of alpha-interferons on immune function.

  1997cited by this paper
• MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.

  1995cited by this paper
• The MAPK signaling cascade

  1995cited by this paper
• Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII.

  1994cited by this paper
• Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.

  1994cited by this paper
• Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation.

  1992cited by this paper
• Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor.

  1992cited by this paper
• Insulin stimulation of gene expression mediated by p21ras activation.

  1991cited by this paper
• Convenient assay for interferons

  1981cited by this paper

• Elucidating the mechanism of stigmasterol in acute pancreatitis treatment: insights from network pharmacology and in vitro/in vivo experiments

  2024cites this paper
• Importance of protein flexibility in ranking ERK2 Type I1/2 inhibitor affinities: a computational study

  2019cites this paper
• High yield expression, characterization, and biological activity of IFNα2-Tα1 fusion protein

  2019cites this paper
• Mycoplasma promotes malignant transformation in vivo, and its DnaK, a bacterial chaperone protein, has broad oncogenic properties

  2018cites this paper
• Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies

  2018cites this paper
• Occlusion Induced by a MEK Inhibitor – Impact of Oxidative Stress on the Blood-Retinal Barrier

  2017cites this paper
• The role of cold‐inducible RNA binding protein in cell stress response

  2017cites this paper
• Signaling of hepatitis C virus

  2015cites this paper
• The Newly Identified T Helper 22 Cells Lodge in Leukemia

  2015cites this paper
• Mnk kinases in cytokine signaling and regulation of cytokine responses

  2015cites this paper
• Increased Frequency of CD49b/LAG-3+ Type 1 Regulatory T Cells in HIV-Infected Individuals

  2015cites this paper
• Cold-inducible RNA-binding protein inhibits neuron apoptosis through the suppression of mitochondrial apoptosis.

  2015cites this paper
• Construction, expression and characterization of human interferon  2b-(G4S)n-thymosin  1 fusion proteins in

  2015cites this paper
• Total chemical synthesis of human interferon alpha‐2b via native chemical ligation

  2015cites this paper
• Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment

  2014cites this paper
• The Treg/Th17 Paradigm in Lung Cancer

  2014cites this paper
• Interferon-β Delivery via Human Neural Stem Cell Abates Glial Scar Formation in Spinal Cord Injury

  2013cites this paper
• Th22 and related cytokines in inflammatory and autoimmune diseases

  2013cites this paper
• Interactions cytokiniques dans le microenvironnement inflammatoire : analyse à large échelle de la réponse aux Interférons de Type I lors la de polarisation des Lymphocytes T auxiliaires

  2013cites this paper
• Interleukin 22-producing CD4+ T cells in malignant pleural effusion.

  2012cites this paper
• Antiviral therapy for recurrent hepatitis C reduces recurrence of hepatocellular carcinoma following liver transplantation

  2012cites this paper
• Retinal Vein Occlusion Induced by a MEK Inhibitor - Impact of Oxidative Stress on the Blood-Retinal Barrier

  2012cites this paper
• Mnk kinases in cytokine signaling and regulation of cytokine responses

  2012cites this paper
• Sequential Proteolytic Processing of an Interferon-Alpha Receptor Subunit by TNF-Alpha Converting Enzyme and Presenilins

  2012cites this paper
• Molecular mechanisms of strain-stimulated intestinal epithelial cell differentiation and migration

  2012cites this paper
• Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.

  2011cites this paper
• Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells

  2011cites this paper
• APC Activation by IFN-α Decreases Regulatory T Cell and Enhances Th Cell Functions

  2010cites this paper
• Mechanisms of mRNA translation of interferon stimulated genes.

  2010cites this paper
• Changes in Glucose and Glutamine Lymphocyte Metabolisms Induced by Type I Interferon α

  2010cites this paper
• Schlafen 3 induction by cyclic strain regulates intestinal epithelial differentiation.

  2010cites this paper
• Type I Interferon Inhibits Astrocytic Gliosis and Promotes Functional Recovery after Spinal Cord Injury by Deactivation of the MEK/ERK Pathway

  2009cites this paper
• PD0325901, a Mitogen-Activated Protein Kinase Kinase Inhibitor, Produces Ocular Toxicity in a Rabbit Animal Model of Retinal Vein Occlusion

  2009cites this paper
• Preferential Upregulation of Interferon-α Subtype 2 Expression in HIV-1 Patients

  2009cites this paper
• Dipeptidyl Peptidase 2 is an essential survival factor in the regulation of cell quiescence

  2009cites this paper
• Antitumor effects of a combination of interferon-alpha and sorafenib on human renal carcinoma cell lines.

  2008cites this paper
• Increased Interferon Alpha Expression in Circulating Plasmacytoid Dendritic Cells of HIV-1-Infected Patients

  2008cites this paper
• Impact of IFNα2b upon pSTAT3 and the MEK/ERK MAPK Pathway in Melanoma

  2008cites this paper
• Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways.

  2008cites this paper
• Mechanism of paroxetine-induced cell death in renal tubular cells.

  2008cites this paper
• Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.

  2007cites this paper
• IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells

  2007cites this paper
• Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells

  2007cites this paper
• RNAi‐mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease‐9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth

  2007cites this paper
• p38 MAP Kinase Regulates Stem Cell Apoptosis in Human Hematopoietic Failure

  2007cites this paper
• Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group.

  2007cites this paper
• Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.

  2006cites this paper
• IL-22-Mediated Tumor Growth Reduction Correlates with Inhibition of ERK1/2 and AKT Phosphorylation and Induction of Cell Cycle Arrest in the G2-M Phase

  2006cites this paper
• From existing therapies to novel targets: a current view on melanoma.

  2006cites this paper
• Inhibition of mitogen‐activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF‐7 cells

  2005cites this paper
• Beyond single pathway inhibition: MEK inhibitors as a platform for the development of pharmacological combinations with synergistic anti-leukemic effects.

  2005cites this paper
• Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines.

  2005cites this paper
• Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.

  2005cites this paper
• Interferon alpha for the treatment of advanced renal cancer

  2005cites this paper
• Alpha‐interferon and its effects on signal transduction pathways

  2005cites this paper
• Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies

  2005cites this paper
• Construction, expression and characterization of human interferon alpha2b-(G4S)n-thymosin alpha1 fusion proteins in Pichia pastoris.

  2005cites this paper
• Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.

  2005cites this paper
• IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling

  2004cites this paper
• Alpha-interferon and its effects on signalling pathways within cells.

  2004cites this paper
• Novel Agents for the Prevention of Breast Cancer: Targeting Transcription Factors and Signal Transduction Pathways

  2004cites this paper
• Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.

  2003cites this paper